Levy RH - Search Results

1

Importance of multi-p450 inhibition in drug-drug interactions: evaluation of incidence, inhibition magnitude, and prediction from in vitro data.

Isoherranen N, Lutz JD, Chung SP, Hachad H, Levy RH, Ragueneau-Majlessi I. Isoherranen N, et al. Among authors: levy rh. Chem Res Toxicol. 2012 Nov 19;25(11):2285-300. doi: 10.1021/tx300192g. Epub 2012 Sep 27. Chem Res Toxicol. 2012. PMID: 22823924 Free PMC article. Review.

2

Prediction of maximum exposure in poor metabolizers following inhibition of nonpolymorphic pathways.

Collins C, Levy R, Ragueneau-Majlessi I, Hachad H. Collins C, et al. Curr Drug Metab. 2006 Apr;7(3):295-9. doi: 10.2174/138920006776359301. Curr Drug Metab. 2006. PMID: 16611023

3

Qualitative analysis of the role of metabolites in inhibitory drug-drug interactions: literature evaluation based on the metabolism and transport drug interaction database.

Isoherranen N, Hachad H, Yeung CK, Levy RH. Isoherranen N, et al. Among authors: levy rh. Chem Res Toxicol. 2009 Feb;22(2):294-8. doi: 10.1021/tx800491e. Chem Res Toxicol. 2009. PMID: 19216580 Free PMC article. Review.

4

Are circulating metabolites important in drug-drug interactions?: Quantitative analysis of risk prediction and inhibitory potency.

Yeung CK, Fujioka Y, Hachad H, Levy RH, Isoherranen N. Yeung CK, et al. Among authors: levy rh. Clin Pharmacol Ther. 2011 Jan;89(1):105-13. doi: 10.1038/clpt.2010.252. Epub 2010 Dec 1. Clin Pharmacol Ther. 2011. PMID: 21124313 Free PMC article.

5

New antiepileptic drugs: review on drug interactions.

Hachad H, Ragueneau-Majlessi I, Levy RH. Hachad H, et al. Among authors: levy rh. Ther Drug Monit. 2002 Feb;24(1):91-103. doi: 10.1097/00007691-200202000-00016. Ther Drug Monit. 2002. PMID: 11805729 Review.

6

Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients.

Ragueneau-Majlessi I, Levy RH, Bergen D, Garnett W, Rosenfeld W, Mather G, Shah J, Grundy JS. Ragueneau-Majlessi I, et al. Among authors: levy rh. Epilepsy Res. 2004 Nov;62(1):1-11. doi: 10.1016/j.eplepsyres.2004.06.008. Epilepsy Res. 2004. PMID: 15519127 Clinical Trial.

7

Quantitative correlations among CYP3A sensitive substrates and inhibitors: literature analysis.

Ragueneau-Majlessi I, Boulenc X, Rauch C, Hachad H, Levy RH. Ragueneau-Majlessi I, et al. Among authors: levy rh. Curr Drug Metab. 2007 Dec;8(8):810-4. doi: 10.2174/138920007782798135. Curr Drug Metab. 2007. PMID: 18220561

8

Interaction between clopidogrel and proton pump inhibitors: hypothesis to explain multifactorial CYP2C19 inhibition.

Zhang H, Ragueneau-Majlessi I, Levy RH. Zhang H, et al. Among authors: levy rh. Drug Metab Lett. 2009 Dec;3(4):287-9. doi: 10.2174/187231209790218136. Drug Metab Lett. 2009. PMID: 19995331

9

A useful tool for drug interaction evaluation: the University of Washington Metabolism and Transport Drug Interaction Database.

Hachad H, Ragueneau-Majlessi I, Levy RH. Hachad H, et al. Among authors: levy rh. Hum Genomics. 2010 Oct;5(1):61-72. doi: 10.1186/1479-7364-5-1-61. Hum Genomics. 2010. PMID: 21106490 Free PMC article.

10

e-PKGene: a knowledge-based research tool for analysing the impact of genetics on drug exposure.

Hachad H, Overby CL, Argon S, Yeung CK, Ragueneau-Majlessi I, Levy RH. Hachad H, et al. Among authors: levy rh. Hum Genomics. 2011 Jul;5(5):506-15. doi: 10.1186/1479-7364-5-5-506. Hum Genomics. 2011. PMID: 21807605 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters